Researchers identify a new player in human immunity that can go rogue and turn the immune system against the body’s own ...

More than 2 years since the original trial data for lecanemab in Alzheimer's disease was published,1 and over 1·5 years since approval by the US Food and Drug Administration, brain volume data have ...

A study just published in the journal Microbiome, describes for the first time the intestinal microbiome and metabolome in ...

In a small study, patients with the syndrome were more likely to experience reactivation of Epstein-Barr virus and high ...

The Human Virome Program will analyze samples from thousands of volunteers in an effort to understand how viruses affect health.

Q: I could use some good news. What important medical breakthroughs happened last year? -- Frank J., Pasadena, California ...

The National Institutes of Health reports that incidences of Alzheimer’s disease and other dementia increased by roughly 148 ...

The Presence looks down at their dead bodies on the driveway below (calling back to the psychic's ominous earlier warning that the spirit was there to stop something to do with "the window that ...

CervoMed Inc. announced that it will present topline results from its Phase 2b RewinD-LB study at the 8th International Lewy Body Dementia Conference in Amsterdam on January 31, 2025. The study ...

Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Premium subscription today. From reproductive rights to climate change to Big Tech, The ...

And because his tariffs programme will challenge World Trade Organization (WTO) rules, Trump is likely to continue the US policy of stymieing the WTO’s appellate body, which adjudicates on trade ...